Patents by Inventor Anita Chugh
Anita Chugh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 8940900Abstract: Compounds of the present disclosure are 2,2,2-tri-substituted acetamide derivatives of formula (I), its polymorphs, stereoisomers, prodrugs, solvates, pharmaceutically acceptable salts and formulations thereof, useful as Glucokinase activator. Processes of their preparation are also described in the disclosure. The disclosure also describes method to characterize partial glucokinase activators.Type: GrantFiled: February 25, 2008Date of Patent: January 27, 2015Assignee: Advinus Therapeutics Private LimitedInventors: Kasim A. Mookhtiar, Debnath Bhuniya, Bhavesh Dave, Gobind S. Kapkoti, Sujay Basu, Anita Chugh, Siddhartha De, Venkata P. Palle
-
Publication number: 20110190296Abstract: The present invention relates to substituted pyrrole derivatives, which can be used as 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors. Compounds disclosed herein can function as cholesterol lowering agents and can be used for the treatment of cholesterol-related diseases and related symptoms. Processes for the preparation of disclosed compounds are provided, as well as pharmaceutical compositions containing the disclosed compounds, and methods of treating cholesterol-related diseases and related symptoms.Type: ApplicationFiled: April 11, 2011Publication date: August 4, 2011Applicant: RANBAXY LABORATORIES LIMITEDInventors: Mohammad SALMAN, Jitendra SATTIGERI, Yatendra KUMAR, Ram Chander ARYAN, Vikram Krishna RAMANATHAN, Anita CHUGH
-
Publication number: 20110190369Abstract: The present invention relates to substituted pyrrole derivatives, which can be used as 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors. Compounds disclosed herein can function as cholesterol lowering agents and can be used for the treatment of cholesterol-related diseases and related symptoms. Processes for the preparation of disclosed compounds are provided, as well as pharmaceutical compositions containing the disclosed compounds, and methods of treating cholesterol-related diseases and related symptoms.Type: ApplicationFiled: April 11, 2011Publication date: August 4, 2011Applicant: RANBAXY LABORATORIES LIMITEDInventors: Mohammad SALMAN, Jitendra SATTIGERI, Yatendra KUMAR, Ram Chander ARYAN, Vikram Krishna RAMANATHAN, Anita CHUGH
-
Patent number: 7923467Abstract: The present invention relates to substituted pyrrole derivatives, which can be used as 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors. Compounds disclosed herein can function as cholesterol lowering agents and can be used for the treatment of cholesterol-related diseases and related symptoms. Processes for the preparation of disclosed compounds are provided, as well as pharmaceutical compositions containing the disclosed compounds, and methods of treating cholesterol-related diseases and related symptoms.Type: GrantFiled: May 28, 2004Date of Patent: April 12, 2011Assignee: Ranbaxy Laboratories, Inc.Inventors: Mohammad Salman, Jitendra Sattigeri, Yatendra Kumar, Ram Chander Aryan, Vikram Krishna Ramanathan, Anita Chugh
-
Publication number: 20100222393Abstract: Compounds of Formula (I), wherein represents a single bond when G is —OH and double bond when G is —O; R1 and R2 are independently selected from hydrogen, alkyl, alkenyl, alkynyl, aralkyl, cycloalkyl, aryl, heteroaryl, heterocyclyl, heterocyclylalkyl or heteroarylalkyl; R3 is selected from the group selected from hydrogen, hydroxy, alkoxy, alkenyloxy or alkynyloxy; X is selected from oxygen, —NH, —NR (wherein R is alkyl, alkenyl, alkenyl, alkynyl or aryl), sulphur or no atom; Het is heterocyclyl or heteroaryl; n is an integer from 1 to 6; are muscarinic receptor antagonists, which are useful, among other uses, for the treatment of various diseases of the respiratory, urinary and 4 i gastrointestinal systems mediated through muscarinic receptors.Type: ApplicationFiled: December 21, 2006Publication date: September 2, 2010Inventors: Naresh Kumar, Jaskiran Kaur, Venkata P. Palle, Beenu Bhatt, Shelly Jindal, Anita Chugh, Suman Gupta, Abhijit Ray, Shivani Malhotra, Raj Kumar Shirumalla
-
Publication number: 20100144772Abstract: Compounds of the present disclosure are 2,2,2-tri-substituted acetamide derivatives of formula (I), its polymorphs, stereoisomers, prodrugs, solvates, pharmaceutically acceptable salts and formulations thereof, useful as Glucokinase activator. Processes of their preparation are also described in the disclosure. The disclosure also describes method to characterize partial glucokinase activators.Type: ApplicationFiled: February 25, 2008Publication date: June 10, 2010Applicant: ADVINUS THERAPEUTICS PRIVATE LIMITEDInventors: Kasim A. Mookhtiar, Debnath Bhuniya, Bhavesh Dave, Gobind S. Kapkoti, Sujay Basu, Anita Chugh, Siddhartha De, Venkata P. Palle
-
Publication number: 20100056602Abstract: The present invention relates to substituted pyrrole derivatives, which can be used as 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors. Compounds disclosed herein can function as cholesterol lowering agents and can be used for the treatment of cholesterol-related diseases and related symptoms. Processes for the preparation of disclosed compounds are provided, as well as pharmaceutical compositions containing the disclosed compounds, and methods of treating cholesterol-related diseases and related symptoms.Type: ApplicationFiled: May 28, 2004Publication date: March 4, 2010Inventors: Mohammad Salman, Jitendra Sattigeri, Yatendra Kumar, Ram Chander Aryan, Vikram Krishna Ramanathan, Anita Chugh
-
Publication number: 20100016400Abstract: The present invention generally relates to muscarinic receptor antagonists, which are useful for treating various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The invention also relates to processes for preparing compounds described herein, pharmaceutical compositions containing the disclosed compounds, and the methods for treating diseases mediated through muscarinic receptors.Type: ApplicationFiled: November 18, 2005Publication date: January 21, 2010Inventors: Naresh Kumar, Mohammad Salman, Kirandeep Kaur, Anita Mehta, Sudershan K. Arora, Anita Chugh
-
Publication number: 20090312344Abstract: The present invention relates to ?1, and/or ?1d adrenergic receptor antagonists, which can function as ?1a and/or ?1d adrenergic receptor antagonist and can be used for the treatment of a disease or disorder mediated through ?1a and/or an adrenergic receptor. Compounds disclosed herein can be used for the treatment of benign prostatic hyperplasia (BPH) and the related symptoms thereof. Further, compounds disclosed herein can be used for the treatment of lower urinary tract symptoms associated with or without BPH. Also provided are processes for preparing such compounds, pharmaceutical compositions thereof, and the methods of treating BPH or related symptoms thereof.Type: ApplicationFiled: May 31, 2005Publication date: December 17, 2009Inventors: Mohammad Salman, Somesh Sharma, Gyan Chand Yadav, Gobind Singh Kapkoti, Anurag Mishra, Praful Gupta, Nitya Anand, Anita Chugh, Kamna Nanda
-
Publication number: 20090176856Abstract: This present invention generally relates to muscarinic receptor antagonists, which are useful, among other uses, for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The invention also relates to the process for the preparation of disclosed compounds, pharmaceutical compositions containing the disclosed compounds, and the methods for treating diseases mediated through muscarinic receptors.Type: ApplicationFiled: September 26, 2005Publication date: July 9, 2009Inventors: Anita Mehta, Mohammad Salman, Pakala Kumara Savithru Sarma, Shelly Aeron, Anita Chugh, Suman Gupta
-
Patent number: 7544708Abstract: This invention generally relates to muscarinic receptor antagonists which are useful, among other uses, for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. Specifically, the invention relates to derivatives of azabicyclo compounds, including, for example, 6-substituted azabicyclo[3.1.0] hexanes, and 2,4,6-trisubstituted derivatives. The invention also relates to pharmaceutical compositions containing the compounds and the methods of treating the diseases mediated through muscarinic receptors.Type: GrantFiled: April 11, 2003Date of Patent: June 9, 2009Assignee: Ranbaxy Laboratories LimitedInventors: Mohammad Salman, Anita Mehta, Pakala Kumara Savithru Sarma, Shankar Jayram Shetty, Sankaranarayanan Dharmarajan, Naresh Kumar, Arundutt Vishwanatham Silamkoti, Anita Chugh
-
Publication number: 20090137623Abstract: The present invention relates to muscarinic receptor modulators, specifically, 7-oxo-2-azabicyclo[2.2.1]heptanes of formula (I) which are useful for the treatment of various diseases and conditions, for example, Alzheimer's disease, glaucoma, psychosis, particularly schizophrenia or schizophreniform conditions, mania, pain, bipolar disorder, depression, sleeping disorders, epilepsy, gastrointestinal motility disorders, urinary incontinence, and cognition enhancement.Type: ApplicationFiled: January 2, 2007Publication date: May 28, 2009Inventors: Naresh Kumar, Ian Anthony Cliffe, Mohammad Salman, Venkata P. Palle, Kirandeep Kaur, Yogesh D. Shejul, Anita Chugh, Suman Gupta, Abhijit Ray, Shivani Malhotra, Raj Kumar Shirumalla
-
Publication number: 20090131410Abstract: Provided are muscarinic receptor antagonists, which can be useful in treating various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. Also provided are processes for preparing compounds described herein, pharmaceutical compositions thereof, and methods for treating diseases mediated through muscarinic receptors.Type: ApplicationFiled: October 5, 2006Publication date: May 21, 2009Inventors: Naresh Kumar, Kirandeep Kaur, Suman Gupta, Anita Chugh, Mohammad Salman, Raj Kumar Shirumalla, Shivani Malhotra
-
Publication number: 20090105221Abstract: This present invention generally relates to muscarinic receptor antagonists of Formula (I), which are useful, among other uses, for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The invention also relates to the process for the prepration of disclosed compounds, pharmaceutical compositions containing the disclosed compounds, and the methods for treating diseases mediated through muscarinic receptors.Type: ApplicationFiled: September 28, 2005Publication date: April 23, 2009Applicant: RANBAXY LABORATORIES LIMITEDInventors: Mohammad Salman, Pakala Kumara Savithru Sarma, Arani Pal, Anita Chugh, Suman Gupta, Venkata P. Palle, Naresh Kumar, Kirandeep Kaur
-
Publication number: 20090012116Abstract: Provided are muscarinic receptor antagonists, which can be useful in treating various diseases of the respiratory, urinary or gastrointestinal system mediated through muscarinic receptors. Also provided are processes for preparing compounds described herein, pharmaceutical compositions comprising compounds described herein, and methods for treating diseases mediated through muscarinic receptors.Type: ApplicationFiled: July 11, 2006Publication date: January 8, 2009Inventors: Naresh Kumar, Kirandeep Kaur, Sandeep Sinha, Suman Gupta, Venkata P. Palle, Anita Chugh
-
Publication number: 20080319002Abstract: This present invention generally relates to xanthine derivatives as muscarinic receptor antagonists which are useful, among other uses, for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The invention also relates to the process for the preparation of disclosed compounds, pharmaceutical compositions containing the disclosed compounds, and the methods for treating diseases mediated through muscarinic receptors.Type: ApplicationFiled: June 16, 2004Publication date: December 25, 2008Applicant: RANBAXY LABORATORIES LIMITEDInventors: Anita Mehta, Mohammad Salman, Pakala Kumara Savithru Sarma, Anita Chugh, Suman Gupta
-
Publication number: 20080319043Abstract: The present invention generally relates to muscarinic receptor antagonists, which are useful, among other uses, for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The invention also relates to the process for the preparation of disclosed compounds, pharmaceutical compositions containing the disclosed compounds, and the methods for treating diseases mediated through muscarinic receptors.Type: ApplicationFiled: May 1, 2006Publication date: December 25, 2008Inventors: Mohammad Salman, Naresh Kumar, Kirandeep Kaur, Shelly Aeron, Pakala Kumara Savithru Sarma, Sankaranarayanan Dharmarajan, Anita Mehta, Anita Chugh
-
Publication number: 20080300251Abstract: The present invention relates to novel 3-azabicyclo[3.1.0]hexane derivatives as dipeptidyl peptidase-IV inhibitors and the processes for the synthesis of the said compounds. This invention also relates to pharmacological compositions containing the compounds of the present invention, and methods of treating diabetes, especially type 2 diabetes, as well as prediabetes, diabetic dyslipidemia, metabolic acidosis, ketosis, satiety disorders, and obesity. These inhibitors can also be used to treat conditions manifested by a variety of metabolic, neurological, anti-inflammatory, and autoimmune disorders like inflammatory disease, multiple sclerosis, rheumatoid arthritis; viral, cancer and gastrointestinal disorders. The compounds of this invention can also be used for treatment of infertility arising due to polycystic ovary syndrome.Type: ApplicationFiled: September 1, 2006Publication date: December 4, 2008Inventors: Jitendra A. Sattigeri, Murugaiah M.S. Andappan, Kaushal Kishore, Sachin Sethi, Sachin Ramesh Kandalkar, Chanchal Kumar Pal, Dipak C. Mahajan, Shahadat Ahmed, Santhosh Sadashiv Parkale, T. Srinivasan, Lalima Sharma, Vinay S. Bansal, Anita Chugh, Joseph Alexanand Davis
-
Publication number: 20080280883Abstract: This present invention generally relates to muscarinic receptor antagonists which are useful, among other uses, for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The invention also relates to the process for the preparation of disclosed compounds, pharmaceutical compositions containing the disclosed compounds, and the methods for treating diseases mediated through muscarinic receptors.Type: ApplicationFiled: September 23, 2005Publication date: November 13, 2008Inventors: Mohammad Salman, Pakala Kumara Savithru Sarma, Sankaranarayanan Dharmarajan, Anita Chugh, Suman Gupta
-
Patent number: 7446123Abstract: This invention generally relates to muscarinic receptor antagonists of formula (I) which are useful, among other uses for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The invention also relates to pharmaceutical compositions containing the compounds of the present invention and the methods of treating the diseases mediated through muscarinic receptors.Type: GrantFiled: January 7, 2004Date of Patent: November 4, 2008Assignee: Ranbaxy Laboratories LimitedInventors: Mohammad Salman, Anita Mehta, Pakala Kumara Savithru Sarma, Naresh Kumar, Sankaranarayanan Dharmarajan, Kirandeep Kaur, Anita Chugh